These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 19783716)

  • 41. [Primary liver cell carcinoma as complication of alpha 1-antitrypsin deficiency in a 67 year old man].
    van den Hazel SJ; Meijer JW; van den Elshout FJ; de Vries RA
    Ned Tijdschr Geneeskd; 2000 Nov; 144(47):2269-72. PubMed ID: 11109473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic control of human alpha-1-antitrypsin.
    Sifers RN; Shen RF; Woo SL
    Mol Biol Med; 1989 Apr; 6(2):127-35. PubMed ID: 2693888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
    Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
    BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
    Franciosi AN; McCarthy C; McElvaney NG
    Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Case detection of alpha1-antitrypsin deficiency: does it help the patient or the doctor?
    Stolk J
    Eur Respir J; 2005 Oct; 26(4):561-2. PubMed ID: 16204582
    [No Abstract]   [Full Text] [Related]  

  • 46. Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications.
    Zuo L; Pannell BK; Zhou T; Chuang CC
    Gene; 2016 Sep; 589(2):118-22. PubMed ID: 26768576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
    Bergin DA; Hurley K; McElvaney NG; Reeves EP
    Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):81-97. PubMed ID: 22349104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hereditary alpha-1-antitrypsin deficiency can cause COPD. Substitution treatment seems to result in fewer infections and prolonged survival].
    Janciauskiene S
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3631-4, 3637-8. PubMed ID: 18193673
    [No Abstract]   [Full Text] [Related]  

  • 50. Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies.
    Ferrarotti I; Corsico AG; Stolk J; Ottaviani S; Fumagalli M; Janciauskiene S; Iadarola P
    COPD; 2017 Feb; 14(1):56-65. PubMed ID: 27827549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015).
    Lior Y; Geyra A; Lewis EC
    Expert Opin Ther Pat; 2016 May; 26(5):581-9. PubMed ID: 26966859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
    Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
    N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A rare case of pulmonary emphysema.
    Sotcan M; Copaci I; Enache M; Jurcuţ C; Duţescu V; Rusu C
    Rom J Intern Med; 2006; 44(4):465-70. PubMed ID: 18386623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha1-antitrypsin deficiency: incidence and implications.
    Richmond RJ; Zellner KM
    Dimens Crit Care Nurs; 2005; 24(6):255-60; quiz 261-2. PubMed ID: 16327507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. alpha 1-Antitrypsin deficiency.
    Catz EG; Speir WA
    South Med J; 1984 Apr; 77(4):479-83. PubMed ID: 6324384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Augmentation therapy with alpha1-antitrypsin: novel perspectives.
    Sabina J; Tobias W
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):90-8. PubMed ID: 23987997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Alpha-1 antitrypsin deficiency].
    Kauppi P; Jokelainen K
    Duodecim; 2011; 127(18):1911-8. PubMed ID: 22034728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Heterozygosity for alpha1-antitrypsin deficiency as a cofactor in the development of chronic liver disease].
    Kok KF; Wahab PJ; de Vries RA
    Ned Tijdschr Geneeskd; 2005 Sep; 149(37):2057-61. PubMed ID: 16184948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alpha1-antitrypsin review.
    Stockley RA
    Clin Chest Med; 2014 Mar; 35(1):39-50. PubMed ID: 24507836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.